New Endogenous Retroviruses Study Results from Agency for Science Technology and Research (ASTAR) Described (Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation).
In: Stem Cell Week, 2024-04-22, S. 1375
serialPeriodical
Zugriff:
A recent study conducted by the Agency for Science Technology and Research (ASTAR) in Singapore explores the challenges of islet transplantation for patients with Type 1 Diabetes (T1D). While this treatment can be life-changing, it requires intensive immunosuppression to prevent rejection of the transplanted cells. The study discusses various advancements in bio-engineering and cell-based approaches to address these immunological challenges, including the use of microencapsulation or macroencapsulation devices and the use of stem cells as a source for generating islet cells. The goal is to improve the accessibility and effectiveness of islet cell therapy while minimizing the need for chronic immunosuppression. [Extracted from the article]
Copyright of Stem Cell Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Endogenous Retroviruses Study Results from Agency for Science Technology and Research (ASTAR) Described (Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation).
|
---|---|
Zeitschrift: | Stem Cell Week, 2024-04-22, S. 1375 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1537-1360 (print) |
Schlagwort: |
|
Sonstiges: |
|